All news

RNAi tools

RNAi tools

Dharmacon, a US supplier of RNA and RNA-interference research
products, announced today it has launched Cell Cycle siARRAY, a
collection of ready-to-use siRNA duplexes designed to knock down
112 genes involved in cell cycle regulation.

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...

Forging genomics

Forging genomics

Biotechnology service group SeqWright has entered into an agreement
with Fisher Scientific that combines SeqWright's services with
Fisher's scientific research products.

Swallowing loss

Swallowing loss

Losses continue for buccal drug delivery company Generex
Biotechnology with the company yesterday reporting a net loss of
$4.6 million (€4.3m), or $(27) per share for the quarter ended
January 31, 2003 - compared to a net loss of...

Go with the flow...

Go with the flow...

A series of new flow cytometry products will soon hit the market
with the announcement yesterday from US companies BD Biosciences
and Molecular Probes that, following a recent license agreement, BD
Biosciences Pharmingen has launched...

A LEAP ahead

A LEAP ahead

Specialists in cellular analysis Cyntellect this week announced the
issuance of a new patent covering the company's Laser Enabled
Analysis and Processing (LEAP) technology platform.

Xenogen in Japan

Xenogen in Japan

SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
Xenogen corporation.

Softly, softly...

Softly, softly...

German pharmaceutical company Boehringer Ingelheim has signed a
long-term agreement with software company MDL Information Systems
to use its software technology for managing and deploying chemical
information systems.

Flaming results

Flaming results

French drug delivery company Flamel Technologies reported a
significant leap in revenues for 2002 jumping from €12.3 million in
2001 to €19.8 million in 2002.

Fund setback for world leader

Fund setback for world leader

Applied Biosystems group, the world's number one maker of
gene-analysing equipment, warned on Tuesday that it would report
lower-than-expected fiscal third-quarter revenue and earnings due
to deteriorating business conditions.